Quanterix CFO Vandana Sriram to Depart as Company Seeks Successor
Event summary
- Vandana Sriram, CFO of Quanterix, will depart on June 15, 2026.
- Sriram joined Quanterix in 2023 and helped establish financial discipline.
- Quanterix acquired Akoya Biosciences in 2025, adding 1,439 installed instruments.
- The company aims for cash flow breakeven and synergy target achievement.
The big picture
Quanterix's CFO transition comes amid its strategic integration of Akoya Biosciences, a move aimed at expanding its capabilities in spatial biology. The company's focus on financial discipline and cash flow breakeven reflects broader trends in the biotech sector, where cost management and operational efficiency are critical for sustaining growth. The departure of a key financial leader could signal shifts in governance or strategic priorities as Quanterix navigates its next phase of development.
What we're watching
- Leadership Continuity
- How the transition of the CFO role will impact financial discipline and strategic execution.
- Integration Progress
- Whether Quanterix can sustain the momentum from the Akoya Biosciences acquisition.
- Financial Milestones
- The pace at which Quanterix achieves cash flow breakeven and synergy targets.
Related topics